| Literature DB >> 28694896 |
Rokas Račkauskas1, Saulius Mikalauskas1, Marius Petrulionis1, Tomas Poškus1, Valdemaras Jotautas1, Juozas Stanaitis2, Eligijus Poškus1, Kęstutis Strupas1.
Abstract
INTRODUCTION: Colorectal cancer (CRC) is the third most common cancer worldwide and the fourth most frequent cause of cancer-related death in the world. CRC screening programs have been widely introduced worldwide, allowing for early detection and removal of precancerous lesions and avoiding major surgical intervention. However, not all polyps are suitable for conventional and advanced colonoscopic polypectomy. Thus, laparoscopically assisted colonoscopic polypectomy (LACP) was introduced to clinical practice as a method of choice for these polyps and adenomas. AIM: To overlook our experience in laparoscopically assisted colonoscopic polypectomies and evaluate effectiveness and quality of the procedure.Entities:
Keywords: colonoscopy; laparoscopically assisted polypectomy; laparoscopy; minimally invasive technique
Year: 2017 PMID: 28694896 PMCID: PMC5502343 DOI: 10.5114/wiitm.2017.68138
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Summary table of patient data. List of enrolled patients and their sex, age, adenoma location, operating time. Distribution of resected adenomas according to histological evaluation, Paris classification
| Patient | Sex | Age [years] | Location | Size [mm] | Operation time [min] | Paris classifi-cation | Hospital stay [days] | Histology | Additional polyps | Compli-cation | Follow-up [months] | Recurrence | Additional treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Female | 81 | Hepatic flexure | 25 | 95 | 0–Is | 3 | Tubulovillous adenoma | 0 | – | – | ||
| 2 | Female | 66 | Cecum | 40 | 100 | 0–Is | 2 | Tubulous adenoma | 3 | – | – | ||
| Sigmoid colon | 35 | 0–Ip | Tubulovillous adenoma + HGD | ||||||||||
| 3 | Male | 71 | Cecum | 10 | 40 | 0–IIa | 1 | Tubulous adenoma | 1 | – | – | ||
| 4 | Female | 57 | Rectum | 20 | 55 | 0–IIa | 1 | Tubulous adenoma | 0 | – | – | ||
| 5 | Male | 61 | Sigmoid colon | 15 | 65 | 0–Is | 2 | Tubulovillous adenoma + HGD | 0 | 6 | Yes | ||
| 6 | Female | 57 | Cecum | 40 | 120 | 0–Ip | 3 | Tubulous adenoma | 2 | 4 | Yes | ||
| 7 | Male | 60 | Ascending colon | 40 | 90 | 0–IIa | 3 | Tubulous adenoma + HGD | 0 | 6 | No | ||
| 8 | Female | 67 | Sigmoid colon | 12 | 65 | 0–Ip | 2 | Tubulous adenoma + LGD | 0 | – | |||
| 9 | Female | 55 | Cecum | 35 | 50 | 0–IIa | 2 | Tubulovillous adenoma | 0 | 27 | No | ||
| 10 | Male | 78 | Cecum | 50 | 120 | 0–III | 10 | Tubulovillous adenoma + HGD | 0 | Bleeding | 13 | Yes | Right hemicolectomy |
| 11 | Female | 54 | Cecum | 25 | 45 | 0–Is | 3 | Tubulovillous adenoma | 0 | – | – | ||
| 12 | Female | 55 | Splenic flexure | 8 | 60 | 0–Is | 1 | Tubulous adenoma | 0 | – | – | ||
| 13 | Female | 59 | Cecum | 20 | 120 | 0–Is | 6 | Tubulovillous adenoma + HGD | 0 | 36 | – | ||
| 14 | Female | 61 | Ascending colon | 30 | 105 | 0–Ip | 9 | Tubulous adenoma | 0 | 14 | Yes | ||
| 15 | Male | 74 | Sigmoid colon | 20 | 85 | 0–IIa | 5 | Tubulous adenoma | 0 | 24 | No | ||
| 16 | Female | 77 | Rectosigmoid | 40 | 150 | 0–Is | 6 | Tubulous adenoma + HGD | 0 | 6 | No | ||
| 17 | Male | 66 | Cecum | 25 | 30 | 0–IIa | 5 | Tubulovillous adenoma | 5 | 6 | No | ||
| 18 | Female | 54 | Cecum | 35 | 95 | 0–Ip | 4 | Tubulovillous adenoma | 0 | – | – | ||
| 19 | Male | 67 | Transverse colon | 20 | 105 | 0–IIa | 3 | Tubulovillous adenoma | 2 | – | – | ||
| 20 | Female | 79 | Hepatic flexure | 30 | 125 | 0–Ip | 4 | Tubulovillous adenoma + HGD | 0 | – | |||
| 21 | Female | 73 | Ascending colon | 20 | 55 | 0–Ip | 3 | Tubulovillous adenoma | 0 | – | – |
HGD – high-grade dysplasia, LGD – low-grade dysplasia.